PARIS, Feb 18 (Reuters) - A patient with terminal heart failure is in "satisfactory condition" two months after becoming the first person to be fitted with Carmat's artificial heart which is designed ...

Carmat requires €3.5m "urgently" and around €35m over the next 12 months to continue operations. Image credit: ArtemisDiana via Shutterstock. · Medical Device Network · ArtemisDiana via Shutterstock.

PARIS, Dec 20 (Reuters) - France's Carmat said on Friday it had carried out its first implant of an artificial heart that can beat for up to five years, adding that the operation had gone smoothly.

PARIS, June 02, 2025--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic ...

PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for ...

The forum brought together more than 100 European leaders in cardiology (cardiologists, surgeons, anaesthetists, intensivists, nurses, specialized distributors, etc ...

A septuagenarian man who was fitted with the French biomedical firm Carmat’s first artificial heart two and half months ago has died, a hospital statement said Monday. “Seventy-five days after the ...

The first 50 implants had been performed over 10 years, between 2013 (the year of Aeson® first human implant) and the end of 2023. Since early 2024, the pace of implants has accelerated sharply ...

PARIS--(BUSINESS WIRE)-- Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for ...

The world’s first receiver of a Carmat artificial heart has died, 75 days after the implant. In a statement on Monday, the Georges Pompidou European Hospital in Paris said it couldn’t yet determine ...

France-based Carmat has filed for insolvency and requested that the Versailles Economic Affairs Court place it in a receivership. The artificial heart manufacturer also suspended trading of its shares ...